ArsenalBio raises $325M in one of the year’s largest biotech funding rounds
BioAge files for IPO, plans pair of midstage obesity trials
US allows increased production of Takeda's ADHD drug to address shortage
Roche trumpets new fenebrutinib data in relapsing MS
*please scroll down for all the latest news*